![](/img/cover-not-exists.png)
A Phase 2 Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Kantarjian, Hagop M., Lioure, Bruno, Atallah, Ehab, Leguay, Thibaut, Kelly, Kevin, Marolleau, Jean-Pierre, Escoffre-Barbe, Martine, Thomas, Xavier G., Kim, Stella K., Cortes, Jorge, Jabbour, Elias, O’Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.12.004
Date:
December, 2015
File:
PDF, 1.37 MB
english, 2015